Pattern-recognition techniques with haplotype analysis in pharmacogenomics

Pharmacogenomics

Volumn 8, Issue 1, 2007, Pages 75-83

  Lin, Eugene ^a   Hwang, Yuchi ^a   Liang, Kung Hao ^a   Chen, Elison Y ^a  

^a VITA GENOMICS INC   (Taiwan)

Author keywords

Association studies; Epistasis; Genomic databases; Haplotypes; Pattern recognition; Pharmacogenomics; Single nucleotide polymorphisms

Indexed keywords

ANTIDEPRESSANT AGENT; CLOZAPINE; FLUVOXAMINE; INTERFERON; RIBAVIRIN;

ARTIFICIAL NEURAL NETWORK; COMPUTER PREDICTION; CORRELATION ANALYSIS; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; GENE CONSTRUCT; GENE FREQUENCY; GENE IDENTIFICATION; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE SEQUENCE; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC CODE; GENETIC DATABASE; GENETIC MARKER; GENETIC VARIABILITY; HAPLOTYPE; HEPATITIS C; HUMAN; LINEAR REGRESSION ANALYSIS; PHARMACOGENETICS; PHENOTYPE; POPULATION RESEARCH; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; GENETIC MARKERS; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; PATTERN RECOGNITION, AUTOMATED; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33846539687     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.1.75     Document Type: Review

References (70)

1. Kwok PY, Gu Z: Single nucleotide polymorphism libraries: why and how are we building them? Mol. Med. Today 5, 538-543 (1999).
2. Johnson GC, Esposito L, Barratt BJ etal.: Haplotype tagging for the Identiftcation of common disease genes. Nat. Genet 29. 233-237 (2001).
3. Deloukas P, Bentley D: The HapMap project and its application to genetic studies of drug response. Pharmacogenomics J. 4, 88-90 (2004).
4. Roses AD: Genome-based pharmacogenetics and the pharmaceutical industry. Nat. Rev. Drug Discov. 1, 541-549 (2002).
5. The International HapMap Consortium: The International HapMap Project. Nature 426, 789-794 (2003).
6. The International HapMap Consortium: The haplotype map of the human genome. Nature 437, 1299-1320 (2005).
7. Hwang Y. Su C, Chen DS, Chen PJ: Prospect of Individualized medicine in chronic hepatitis C therapy by pharmacogenomics. Current Pharmacogenomics 4(2), 157-167 (2006).
8. Chen, X, Sullivan PF: Single nudeotide polymorphism genotyping: biochemistry, protocol, cost and throughput. Pharmacogenomics J. 3, 77-96 (2003).
9. Gabriel SB, Schaffner SF, Nguyen H et ai.: The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002).
10. Hinds DA, Stuve LL, Nilsen G.B et al.: Whole-genome patterns of common DNA variation in three human populations. Science 307, 1072-1079 (2005).
11. Bell JT, Wallace C, Dobson R et al.: Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension. Hum. Mol. Genet. 15, 1365-1374 (2006).
12. Cariborg O, Haley CS: Epistasis: too often neglected in complex trait studies. Nature 5. 618-625 (2004).
13. Crawford DC, Nickerson DA: Definition and clinical Importance of haplotypes. Annu. Rev. Med. 56, 303-320 (2005).
14. Clark AG: Inference of haplotype from PCR-amplified samples of diploid populations. Mol. Biol. Evol. 7(2), 111-122 (1990).
15. Excoffier L, Slatkin M: Maximurn-likelihood estimation of molecular haplotype frequencies in a diploId population. Mol. Biol. Evol. 12, 921-927 (1995).
16. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978-989 (2001).
17. Niu T, Qin ZS, Xu X, Liu JS: Bayestan haplotype inference for multiple linked single-nucleotide polymorphisms. Am. J. Hum. Genet. 70, 157-169 (2002).
18. Stephens M, Donnelly P: A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 73, 1162-1169 (2003).
19. Scheet P, Stephens M: A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am. J. Hum. Genet. 78(4), 629-44 (2006).
20. Ding K, Zhou K, Zhang J, Knight J, Zhang X. Shen Y: The effect of haplotype-block definitions on inference of haplotype-block structure and htSNPs selection. Mol. Biol. Evol. 22(1), 148-159 (2005).
21. Wang N. Akey JM, Zhang K, Chakraborty R, Jin L: Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am. J. Hon. Genet. 71, 1227-1234 (2002).
22. Patil. N, Berno AJ, Hinds DA et al.: Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294, 1719-1723 (2001).
23. Zhang K, Deng M, Chen T, Waterman MS. Sun FZ: A dynamic programming algorithm for haplotype block partitioning. Proc. Natl. Acad. Sci. USA 99, 7335-7339 (2002).
24. Schulze TG, Zhang K, Chen YS, Akula N, Sun F, McMahon FJ: Defining haplotype blocks and tag single-nucleotide polymorphisms in the human genome. Hum. Mol. Genet 13(3). 335-342 (2004).
25. Halperin E, Eskin E: Haplotype Reconstruction from genotype data using imperfect phylogeny. Bioinformatics 20 (12), 1842-1849 (2004).
26. Barrett JC, Fry B, Maller J., Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265(2005).
27. de Bakker PI, Yelensky R. Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet. 37(11),1217-1223 (2005).
28. Stram DO, Haiman CA, Hirschhorn JN et al.: Choosing haplotype-tagging SNPs based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the multiethnic cohort study. Hum Hered. 55, 27-36 (2003).
29. Zhang J, Rowe WL, Struewing JP, Buetow KH: HapScope: a software system for automated and visual analysis of functionally annotated haplotypes. Nucleic Acids Res. 30(23), 5213-5221 (2002).
30. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L. Nickerson DA: Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet 74(1), 106-120 (2004).
31. Howie BN, Carlson CS, Rieder MJ, Nickerson DA: Efficient selection of tagging single-nucleotide polymorphisms in multiple populations. Hum. Genet. 120(1), 58-68 (2006).
32. Hwang Y, Chen EY, Gu ZJ et al.: Genetic predisposition of responsiveness to therapy for chronic hepatitis C. Pharmacogenomics 7(5), 697-709 (2006).
33. Lin E, Hwang Y, Tzeng CM: A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population. Mol. Diagn. Ther. 10(6) 367-370 (2006).
34. Lin M, Wu R: Theoretical basis for the identification of allelic variants that encode drug efficacy and toxicity. Genetics 170(2). 919-928 (2005).
35. Fallin D, Cohen A, Essioux L et al.: Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer'disease. Genome Res. 11, 143-151 (2001).
36. Tzeng JY, Wang CH, Kao JT, Hsiao CK: Regression-based association analysis with clustered haplotypas through use of genotypes. Am. J. Hum. Genet 78, 231-242 (2004).
37. Hirschhorn JN, Daly MI: Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95-108 (2005).
38. Nyholt DR: A simple correction for multiple testing for single-nucleotide polymorphism in Linkage Disequilibrium with each other. Am. J. Hum. Genet. 74, 765-769 (2004).
39. Becker T, Knapp M: Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet. Epidemiol. 27, 21-32 (2004).
40. Epstein MP, Satten GA: Inference on haplotype effects in case-control studies using unphased genotype data. Am. J. Hum. Genet. 73, 1316-1329 (2003).
41. Dudbridge F: Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25, 115-221 (2003).
42. Sargent DJ: Comparison of artificial neural networks with other statistical approaches. Cancer 91(8), 1636-42 (2001).
43. McCullagh P, Nelder JA. Generalized Linear Models (2nd Edition). Chapman and Hall. London, UK (1989).
44. Yamanouchi Y, Iwata N, Suzuki T, Kitajima T, Ikeda M, Ozaki N: Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone. Pharmacogenomics J. 3, 356-361 (2003).
45. Arranz MJ, Munro J, Birkett J et al: Pharmacogenetic prediction of clozapine response. Lancet 355 (9215), 1615-1616 (2000).
46. Zheng B, Agresti A: Summarizing the predictive power of a generalized linear model. Stat. Med. 19, 1771-1781 (2000).
47. Kung SY, Hwang JN: Neural networks for intelligent multimedia processing. Proc. IEEE Inst. Electr. Electron. Eng. 86, 1244-1272 (1998).
48. Lin E, Hwang Y, Wang SC. Gu ZJ, Chen EY:. An artificial neural network approach to the drug efficacy of interferon treatments. Pharmacogenomics 7 (7), 1017-1024 (2006).
49. Rumelhart DE, Hinton GE, William RJ: Learning internal representation by error propagation. In: Parallel Distributed Processing: Explorations in the Microstructures of Cognition (vol. 1), Foundations. Rumelhart DE, McClelland JL (Eds) - MIT Press, MA, USA (1986).
50. Serretti A, Smerald E: Neural network analysis in pharmacogenetics of mood disorders. BMC Med. Genet. 5, 27 (2004).
51. Bishop C: Neural Networks for Pattern Recognition. Oxford University Press, Oxford, UK (1995).
52. Eftekhar B, Mohammad K, Ardebili HE, Ghodsi M, Ketabchi E: Comparison of artificial neural network and logistic regression models for prediction of mortality in head trauma based on initial clinical data. BMC Med. Inform. Decis. Mak. 5, 3 (2005).
53. North BV, Curtis D, Cassell PG. Hitman GA, Sham PC: Assessing optimal neural network architecture for identifying disease-associated multi-marker genotypes using a permutation test, and application to calpain 10 polymorphisms associated with diabetes. Ann. Hum. Genet. 67, 348-356 (2003).
54. Coffey CS, Hebert PR, Ritchie MD et al: An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene Interactions on risk of myocardial infarction: the importance of model validation. BMC Bioinformatics 5, 49 (2004).
55. Onay VU, Briollais L, Knight JA et al.: SNP-SNP interactions in breast cancer susceptibility. BMC Cancer 6, 114 (2006).
56. Breiman L, Friedman JH, Olshen RA, Stone CJ: Classification and Regression Trees. Wadsworth, CA, USA (1984).
57. Friedman JH: Multivariate adaptive regression splines. The Annals of Statistics 19, 1-67 (1991).
58. Huang J, Lin A, Narasimhan B et al.: Tree-structured supervised learning and the genetics of hypertension. Proc. Natl. Acad. Sci. USA 101(29), 10529-10534 (2004).
59. Ruczinski I, Kooperberg C, LeBlane M: Logic regression. J. Comput. Graph. Stat. 12, 475-511 (2003).
60. Kooperberg C, Bis JC, Marciante KD, Heckbert SR, Lumley T, Psaty BM: Logic regression for analysis of the association between genetic variation in the renin-angiotensin system and myocardial infarction or stroke. Am. J. Epidemiol. (2006).
61. Ma DQ, Whitehead PL, Menold MM, et al: Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am. J. Hum. Genet. 77(3), 377-388 (2005).
62. Hahn LW, Ritchie MD, Moore JH: Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19, 376-382 (2003).
63. Cook NR, Zee RY, Ridker PM: Tree and spline based association analysis of gene-gene interaction models for ischemic stroke. Stat. Med. 23(9), 1439-1453 (2004).
64. Ritchie MD. Motsinger AA: Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. Pharmacogenomics 6(8), 823-34 (2005).
65. Liang KH, Hwang Y, Shao WC, Chen EY: An algorithm for model construction and its applications to pharmacogenomic studies. J. Hum. Genet. 51, 751-759 (2006).
66. Tomita Y, Tomida S, Hasegawa Y et al.: Artificial neural network approach for selection of susceptible single nucleotide polymorphisms and construction of prediction model on childhood allergic asthma. BMC Bioinformatics 5, 120 (2004).
67. Ritchie MD. White BC, Parker JS, Hahn LW, Moore JH: Optimization of neural network architecture using genetic programming Improves detection and modeling of gene-gene interactions in studies of human diseases. BMC Bioinformatics 4, 28 (2003).
68. Koza JR: Genetic Programming: On the Programing of Computers by Means of Natural Selection. MIT Press, MA, USA (1992).
69. Hsieh CH, Liang KH, Hung YR et al: Analysis of epistas, for diabetic nephropathy among Type 2 diabetic patients. Hum. Mol. Genet. 15, 2701-2708 (2006).
70. Marchini J. Donnelly R Cardon LR: Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat. Genet. 37, 413-417 (2005).